港股異動 | 諾輝健康-B(6606.HK)漲超6% 與平安好醫生合作推廣癌症早篩
格隆匯7月7日丨諾輝健康-B(6606.HK)拉昇漲超6%,現報75.25港元,總市值323億港元。
諾輝健康公佈,與平安好醫生簽署戰略合作協議,雙方將合作推廣與普及癌症早篩,整合資源並共同推進互聯網居家檢測創新,探索從癌症預防到診療的一體化醫療健康服務發展。
值得一提的是,在今年618期間諾輝健康京東旗艦店獲得京東基因檢測類目行業銷售額、單品銷售額雙冠軍。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.